特殊类型高血压临床诊治要点专家建议

2020-03-20 中国中医药研究促进会 中国全科医学.2020.23(10):1202-1228.

为了更好地配合国家推进高血压诊断治疗落实到基层,使基层医生更好地掌握特殊情况下高血压的精准治疗,编写了《特殊类型高血压临床诊治要点专家建议》。

中文标题:

特殊类型高血压临床诊治要点专家建议

发布日期:

2020-03-20

简要介绍:

为了更好地配合国家推进高血压诊断治疗落实到基层,使基层医生更好地掌握特殊情况下高血压的精准治疗,编写了《特殊类型高血压临床诊治要点专家建议》。

该专家建议共18 个章节,从高血压的特殊类型、特殊人群、特殊背景等方面,对各种特殊类型高血压的特征进行了深入浅出、全面详实的阐述。具有以下特点:(1)详实阐述了围术期高血压、药物与高血压、肿瘤与高血压等继发性高血压及女性高血压、老年高血压、儿童青少年高血压、卧位高血压与立位低血压,以及合并了冠心病、心律失常、心力衰竭、心理障碍、免疫系统疾病、睡眠呼吸暂停综合征、脑部疾病等不同合并症的高血压;(2)简明扼要探讨了不同临床背景下的病因机制、病理生理改变、诊治思路、特殊用药原则等;(3)阐述了特殊类型高血压的规范化诊治新思路和具体策略;(4)探讨了相关疾病防治的最新进展,如中心动脉压、左右心功能在特殊类型高血压精准治疗中的作用与地位。该专家建议是落实健康中国行动的重要举措,有助于促进高血压防控工作的规范化,敬请关注。

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=e20f31c00188991b, title=特殊类型高血压临床诊治要点专家建议, enTitle=, guiderFrom=中国全科医学.2020.23(10):1202-1228., authorId=0, author=, summary=为了更好地配合国家推进高血压诊断治疗落实到基层,使基层医生更好地掌握特殊情况下高血压的精准治疗,编写了《特殊类型高血压临床诊治要点专家建议》。, cover=https://img.medsci.cn/2020413/1586770981928_2020535.jpg, journalId=0, articlesId=null, associationId=1011, associationName=中国中医药研究促进会, associationIntro=中国中医药研究促进会,于1989年12月28日正式成立,是由中国农工民主党中央委员会主办,国家中医药管理局业务主管,由我国国医大师与各中医药科研院所、中医药院校、中医医院、中医药企业与其主要负责人或著名专家以及主管中医药行业的政府有关部门负责人,与热心支持关心中医药发展事业的多界人士为主组成,是国家民政部正式批准成立的全国性一级社会组织。 中医药研究促进会以&ldquo;团结广大中医药界同仁和关心祖国传统医学发展的海内外各界人士,研究和促进祖国传统医药及其科技的发展,提高我国人民与世界人民的健康水平和建设有祖国特色的医药卫生事业服务&rdquo;为宗旨。业务范围包括:中医药理论研究;产业政策研讨;学术交流;专业培训;评比表彰;科普宣教;信息咨询;市场调研;专业技术服务;成果产业化推广以及国际合作与交流等。, copyright=0, guiderPublishedTime=Fri Mar 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p style="color: #373737;">为了更好地配合国家推进高血压诊断治疗落实到基层,使基层医生更好地掌握特殊情况下高血压的精准治疗,编写了《特殊类型高血压临床诊治要点专家建议》。</p> <p style="color: #373737;">该专家建议共18 个章节,从高血压的特殊类型、特殊人群、特殊背景等方面,对各种特殊类型高血压的特征进行了深入浅出、全面详实的阐述。具有以下特点:(1)详实阐述了围术期高血压、药物与高血压、肿瘤与高血压等继发性高血压及女性高血压、老年高血压、儿童青少年高血压、卧位高血压与立位低血压,以及合并了冠心病、心律失常、心力衰竭、心理障碍、免疫系统疾病、睡眠呼吸暂停综合征、脑部疾病等不同合并症的高血压;(2)简明扼要探讨了不同临床背景下的病因机制、病理生理改变、诊治思路、特殊用药原则等;(3)阐述了特殊类型高血压的规范化诊治新思路和具体策略;(4)探讨了相关疾病防治的最新进展,如中心动脉压、左右心功能在特殊类型高血压精准治疗中的作用与地位。该专家建议是落实健康中国行动的重要举措,有助于促进高血压防控工作的规范化,敬请关注。</p>, tagList=[TagDto(tagId=274, tagName=高血压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=274, guiderKeyword=高血压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2592, appHits=327, showAppHits=24, pcHits=727, showPcHits=2439, likes=0, shares=26, comments=4, approvalStatus=1, publishedTime=Mon Apr 13 19:19:40 CST 2020, publishedTimeString=2020-03-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Apr 13 17:43:07 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Tue Jan 02 01:06:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2103921, encodeId=c471210392174, content=让我瞅瞅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54508461068, createdName=ms7000001331400588, createdTime=Fri Dec 02 14:32:54 CST 2022, time=2022-12-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1181655, encodeId=e83f118165558, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 00:07:03 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887393, encodeId=2bed88e39358, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76431956246, createdName=1e126935m22(暂无匿称), createdTime=Tue Sep 22 17:17:07 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
    2022-12-02 ms7000001331400588 来自北京

    让我瞅瞅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2103921, encodeId=c471210392174, content=让我瞅瞅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54508461068, createdName=ms7000001331400588, createdTime=Fri Dec 02 14:32:54 CST 2022, time=2022-12-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1181655, encodeId=e83f118165558, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 00:07:03 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887393, encodeId=2bed88e39358, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76431956246, createdName=1e126935m22(暂无匿称), createdTime=Tue Sep 22 17:17:07 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
    2022-01-07 ms7000000167247375

    学习#学习#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2103921, encodeId=c471210392174, content=让我瞅瞅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54508461068, createdName=ms7000001331400588, createdTime=Fri Dec 02 14:32:54 CST 2022, time=2022-12-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1181655, encodeId=e83f118165558, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 00:07:03 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887393, encodeId=2bed88e39358, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76431956246, createdName=1e126935m22(暂无匿称), createdTime=Tue Sep 22 17:17:07 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

拓展阅读

2009ESH 欧洲高血压指南重新评估

欧洲高血压学会(ESH,European Society of Hypertension) · 2009-11-01

2010 台湾高血压管理指南(英文版)

台湾心脏病学会(TSOC,Taiwan Society of Cardiology) · 2010-01-01

2010年中国肺高血压诊治指南

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2010-01-01

2010高血压患者胆固醇管理临床指导建议

中国心血管相关专家小组(统称) · 2010-02-01

2009年基层版《中国高血压防治指南》

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2010-02-10

2010 中国急诊高血压管理专家共识

中国医师协会急诊医师分会(CHINESE COLLEGE OF EMERGENCY PHYSICANS,CCEP) · 2010-03-19